PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+33.39%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$1.75B
AUM Growth
+$1.75B
(+25%)
Cap. Flow
+$113M
Cap. Flow
% of AUM
6.45%
Top 10 Holdings %
Top 10 Hldgs %
46.67%
Holding
235
New
45
Increased
31
Reduced
38
Closed
62
Top Buys
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$50.5M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$26.9M |
| 3 |
Evolent Health
EVH
|
$25.3M |
| 4 |
RDUS
Radius Health, Inc.
RDUS
|
$25M |
| 5 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$24.5M |
Top Sells
| 1 |
TSRO
TESARO, Inc.
TSRO
|
$68.8M |
| 2 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$39.5M |
| 3 |
Sarepta Therapeutics
SRPT
|
$29.6M |
| 4 |
CLCD
CoLucid Pharmaceuticals, Inc.
CLCD
|
$23.3M |
| 5 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$13.5M |
Sector Composition
| 1 | Healthcare | 93.5% |
| 2 | Consumer Discretionary | 0.07% |
| 3 | Industrials | 0.03% |
| 4 | Technology | 0.03% |
| 5 | Energy | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QTNT
26
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $20.4M | 1.16% |
72,945
+1,583
| +2% | +$442K |
|
|
NVRO
27
DELISTED
NEVRO CORP.
NVRO
| $20.4M | 1.16% |
+217,292
| New | +$20.4M |
|
|
KDMN
28
DELISTED
Kadmon Holdings, Inc.
KDMN
| $18.8M | 1.07% |
5,185,847
+2,976,190
| +135% | +$10.8M |
|
|
BPMC
29
DELISTED
Blueprint Medicines
BPMC
| $18.5M | 1.05% |
461,642
+187,822
| +69% | +$7.51M |
|
30
Wave Life Sciences
WVE
$1.27B
| $18.3M | 1.04% |
665,198
| – | – |
|
|
XLRN
31
DELISTED
Acceleron Pharma Inc.
XLRN
| $17.6M | 1% |
663,857
+43,870
| +7% | +$1.16M |
|
32
Talphera
TLPH
$11.2M
| $17M | 0.97% |
270,436
| – | – |
|
33
Assembly Biosciences
ASMB
$183M
| $16.9M | 0.96% |
55,363
-4,167
| -7% | -$1.27M |
|
|
AVDL
34
Avadel Pharmaceuticals
AVDL
$1.42B
| $13.6M | 0.78% |
1,408,240
+20,000
| +1% | +$194K |
|
35
Aldeyra Therapeutics
ALDX
$350M
| $12.9M | 0.73% |
2,885,458
+945,000
| +49% | +$4.22M |
|
|
AMAG
36
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $12.6M | 0.72% |
560,000
+540,476
| +2,768% | +$12.2M |
|
37
ANI Pharmaceuticals
ANIP
$2.06B
| $12.6M | 0.72% |
254,889
-12,211
| -5% | -$605K |
|
|
CORI
38
DELISTED
Corium International, Inc.
CORI
| $11.1M | 0.63% |
+2,654,485
| New | +$11.1M |
|
|
ABMD
39
DELISTED
Abiomed Inc
ABMD
| $10.6M | 0.61% |
85,000
+84,891
| +77,882% | +$10.6M |
|
40
Corbus Pharmaceuticals
CRBP
$121M
| $10.3M | 0.59% |
41,667
| – | – |
|
41
iRhythm Technologies
IRTC
$5.67B
| $10.2M | 0.58% |
271,057
-81,184
| -23% | -$3.05M |
|
|
CLVS
42
DELISTED
Clovis Oncology, Inc.
CLVS
| $10M | 0.57% |
157,754
-10,000
| -6% | -$637K |
|
43
Bio-Rad Laboratories Class A
BIO
$7.8B
| $9.85M | 0.56% |
49,416
+25,000
| +102% | +$4.98M |
|
44
Exact Sciences
EXAS
$9.33B
| $9.68M | 0.55% |
+410,000
| New | +$9.68M |
|
|
ATRS
45
DELISTED
Antares Pharma, Inc.
ATRS
| $8.29M | 0.47% |
2,917,253
| – | – |
|
|
MYOK
46
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $8.21M | 0.47% |
624,694
| – | – |
|
47
Sonida Senior Living
SNDA
$477M
| $8.09M | 0.46% |
38,345
+17,000
| +80% | +$3.59M |
|
|
ALDR
48
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $7.99M | 0.46% |
384,169
| – | – |
|
|
FWP
49
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $7.63M | 0.43% |
50,606
-5,714
| -10% | -$862K |
|
50
uniQure
QURE
$954M
| $7.32M | 0.42% |
1,265,963
| – | – |
|